跳至主要内容
临床试验/PACTR201808177464681
PACTR201808177464681招募中4 期

Reduction of low birth weight at delivery through the adjunction of oral azithromycin to the intermittent preventive treatment of malaria in pregnant women: a randomized controlled trial in rural Burkina Faso

clinical research unit of nanoro0 个研究点目标入组 942 人开始时间: 2018年7月31日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
942

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • 1. Being a pregnant woman between 16 and 32 weeks of pregnancy
  • 2. At least 15 years old; and under 44 years old
  • 3. Residence within the health facility catchment’s area,
  • 4. Willingness to deliver at the health facility;
  • 5. Willingness to adhere to the study protocol requirements;
  • 6. Ability to provide written informed consent.

排除标准

  • 1. History of allergic reactions to the study drugs;
  • 2. History of known pregnancy complications or bad obstetric history such as repeated stillbirths or eclampsia;
  • 3. History or presence of major illnesses likely to influence pregnancy outcome including diabetes mellitus, severe renal or heart disease, or active tuberculosis;
  • 4. Multiple pregnancies (i.e. twin/triplets);
  • 5. Current cotrimoxazole prophylaxis or anti-retroviral therapy (ART);
  • 6. Any significant ongoing condition that requires hospitalization, including severe malaria;
  • 7. Intent to move out of the study catchment area before delivery or deliver at relative’s home out of the catchment area;
  • 8. Prior enrollment in the study or concurrent enrollment in another study;
  • 9. Unable to take oral medication;
  • 10. Clear evidence of recent treatment with artemisinin based combination treatment (ACT), SP or azithromycin during the first trimester of pregnancy, etc.

研究者

发起方
clinical research unit of nanoro

相似试验

招募中
不适用
Effect of aggressive nutrition strategies on neurodevelopment of preterm babies
CTRI/2017/09/009818il260
招募中
1 期
Human milk lyophilisate - Phase 1 and 2 study: safety, tolerability and effectivenessPreterm newbornHuman MilkHuman Milk BancNewrbornM01.060.703.520M01.060.703.520.520A12.200.467N02.278.065.600
RBR-8nnpfmConselho Nacional de Desenvolvimento Científico e Tecnológico
已完成
不适用
The ProVIDe Study. The effect of higher intravenous protein intake for extremely low birthweight babies in the first week after birth on survival free from neurodevelopmental disability at 2 years' corrected age.Extremely preterm birthFaltering growth / postnatal growth restrictionNeurodevelopmental outcome following preterm birthDiet and Nutrition - Other diet and nutrition disordersReproductive Health and Childbirth - Complications of newborn
ACTRN12612001084875Professor Frank Bloomfield434
已完成
不适用
In extremely low birth weight (ELBW) infants who require positive pressure at birth does the use of a respiratory Function Monitor reduce face mask leak and improve the target tidal volume in the first ten minutes of life?Does the use of a respiratory Function Monitor during positive pressure ventilation reduce face mask leak and improve the target tidal volume in the first ten minutes of life?Reproductive Health and Childbirth - Complications of newborn
ACTRN12608000357358Professor Colin J Morley70
已完成
不适用
In extremely low birth weight (ELBW) infants who require positive pressure at birth does the Neopuff Infant Resuscitator compared with the Laerdal Infant Bag improve oxygen saturation measurements in the first ten minutes of life?Oxygen saturation in the first ten minutes of life in infants born at less than 29 weeks gestation who require positive pressure ventilationReproductive Health and Childbirth - Childbirth and postnatal care
ACTRN12607000062426Professor Colin J Morley76
Reduction of low birth weight at delivery through... | 临床试验